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Objectives. We determined the short-term effects of single-
chamber ventricular pacing and dual-chamber atrioventricular
(AV) pacing on directly measured sympathetic nerve activity.
Background. Dual-chamber AV cardiac pacing results in
greater cardiac output and lower systemic vascular resistance
than does single-chamber ventricular pacing. However, it is
unclear whether these hemodynamic advantages result in less
sympathetic nervous system outﬂow.
Methods. In 13 patients with a dual-chamber pacemaker, we
recorded the electrocardiogram, noninvasive arterial pressure
(Finapres), respiration and muscle sympathetic nerve activity
(microneurography) during 3 min of underlying basal heart rate
and 3 min of ventricular and AV pacing at rates of 60 and
100 beats/min.
Results. Arterial pressure was lowest and muscle sympathetic
nerve activity was highest at the underlying basal heart rate.
Arterial pressure increased with cardiac pacing and was greater
with AV than with ventricular pacing (change in mean blood
pressure  SE: 10  3 vs. 2  2 mm Hg at 60 beats/min; 21  5
vs. 14  2 mm Hg at 100 beats/min; p < 0.05). Sympathetic nerve
activity decreased with cardiac pacing and the decline was greater
with AV than with ventricular pacing (60 beats/min40 11% vs.
17  7%; 100 beats/min 60  9% vs. 48  10%; p < 0.05).
Although most patients showed a strong inverse relation between
arterial pressure and muscle sympathetic nerve activity, three
patients with severe left ventricular dysfunction (ejection fraction
<30%) showed no relation between arterial pressure and sympa-
thetic activity.
Conclusions. Short-term AV pacing results in lower sympa-
thetic nerve activity and higher arterial pressure than does
ventricular pacing, indicating that cardiac pacing mode may
inﬂuence sympathetic outﬂow simply through arterial baroreﬂex
mechanisms. We speculate that the greater incidence of adverse
outcomes in patients treated with single-chamber ventricular
rather than dual-chamber pacing may be due in part to increased
sympathetic nervous outﬂow.
(J Am Coll Cardiol 1996;28:1753–8)
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Atrioventricular (AV) synchronous cardiac pacing has distinct
hemodynamic advantages over ﬁxed rate ventricular pacing.
Dual-chamber AV (DDD) pacing yields a larger cardiac
output (1–4) and a smaller systemic vascular resistance (5)
than does single-chamber ventricular (VVI) pacing. Although
short-term AV synchronous pacing may not differentially affect
arterial pressure (3,6), long-term pacing in this mode results in
a higher and more stable arterial pressure with fewer episodes
of hypotension (7). It is unclear whether these hemodynamic
advantages are translated into less sympathetic nervous system
outﬂow. Estimates of overall sympathetic nervous activity have
shown both less (6) and equal (3,8) sympathetic outﬂow with
AV synchronous pacing than with ﬁxed rate ventricular pacing.
However, these estimates of sympathetic activity were derived
from plasma norepinephrine and cyclic adenosine monophos-
phate (AMP) concentrations, which are not solely determined
by the rate of norepinephrine release (9,10). Establishing the
degree of sympathoexcitation during AV and ventricular pac-
ing is clinically relevant because of the known deleterious
effects of long-term elevations in sympathetic activity (11,12).
Atrial ﬁbrillation is more likely to develop (13,14) and the
mortality rate is higher (15–18) in patients treated with VVI
pacing than in patients treated with DDD pacing; conceivably,
the detrimental effects of single-chamber pacing are mediated
in part by relatively higher levels of sympathetic activity.
However, indirect measures of sympathetic nervous system
activity have not documented any autonomic advantages of AV
synchronous pacing.
The purpose of this study was to compare muscle sympa-
thetic nervous activity measured directly from the peroneal
nerve during short-term dual-chamber AV pacing and single-
chamber ventricular pacing. Beat by beat muscle sympathetic
nervous outﬂow to the vasculature is controlled primarily by
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arterial baroreﬂex responses to arterial pressure; increases in
pressure result in baroreﬂex-mediated decreases in sympa-
thetic outﬂow (19). We hypothesized that DDD pacing pro-
duces less sympathetic nerve activity as a result of greater
arterial pressures than those associated with VVI pacing. To
determine whether this effect is rate dependent, we compared
sympathetic nerve responses during dual- and single-chamber
pacing at both 60 and 100 beats/min.
Methods
Study patients. Thirteen male patients (mean age  SE
62  3 years) with a dual-chamber cardiac pacemaker partic-
ipated in this study. Indications for permanent pacing included
complete heart block in eight patients, sick sinus syndrome in
four and carotid sinus hypersensitivity in one patient (Table 1).
Four patients had New York Heart Association class III or IV
congestive heart failure; no other patients had evidence of
clinical congestive heart failure. Ejection fraction was deter-
mined previously by echocardiography in all patients (mean
43  3%). The study protocol was approved by the Institu-
tional Review Boards of the Hunter Holmes McGuire Depart-
ment of Veterans Affairs Medical Center and the Medical
College of Virginia. All patients gave verbal and written
informed consent.
Study measurements and protocol. Surface electrocardio-
graphic (ECG) lead II, continuous noninvasive arterial pres-
sure (Finapres Ohmeda 2300) and respiratory excursions
(pneumobelt connected to a strain gauge transducer) were
recorded throughout the study. Multiunit postganglionic mus-
cle sympathetic nerve activity was measured with use of a
tungsten microelectrode inserted into the right peroneal nerve
near the ﬁbular head, as previously described (20). The raw
nerve signal was ampliﬁed, rectiﬁed and integrated before
recording (Nerve Trafﬁc Analyzer, Model 662c-3, University of
Iowa Bioengineering). Recordings of muscle sympathetic
nerve activity were conﬁrmed by the relation of nervous
activity to the cardiac cycle and to respiratory activity and by
the increase in activity during Valsalva straining.
Patients were studied in the fasting state in the supine
position. All cardioactive medications were withheld 24 h
before the study. After the location of an adequate nerve
recording, measurements were made during the last 3 of 5 min
in each pacing mode. Initial measurements of sympathetic
activity were made at the underlying basal heart rate (52  3
beats/min) in 11 of 13 patients (7 patients had sinus rhythm, 3
had a junctional rhythm and 1 patient had atrial ﬂutter; 2
patients with no underlying escape rhythm were not included
in comparisons with basal heart rate). Subsequently, measure-
ments were made with VVI pacing at rates of 60 and 100
beats/min and with DDD pacing at AV delays of 150, 200 and
250 ms and rates of 60 and 100 beats/min. In patients with AV
node conduction, pacing was not performed at those AV
delays that allowed nonpacemaker-dependent ventricular ac-
tivation; therefore, not all patients underwent pacing at each
delay in the DDD pacing mode.
Data analysis and statistics. The ECG, arterial pressure,
respiration and muscle sympathetic nerve activity waveforms
were recorded on FM tape and subsequently digitized at 250
samples/s for off-line analysis with signal-processing software
(CODAS, Dataq Instruments). Average heart rate and average
systolic and diastolic pressures were calculated from the beat
Abbreviations and Acronyms
AV  atrioventricular
DDD  dual-chamber atrioventricular
ECG  electrocardiogram
VVI  single-chamber ventricular
Table 1. Clinical Characteristics of the 13 Study Patients
Pt
No.
Age (yr)/
Gender
Ejection
Fraction (%)
Basal
Heart Rate
(beats/min)
Heart
Disease Pacing Indications
1 75/M 45 55 CAD, CABG Complete heart block
2 70/M 55 59 CAD, HTD Complete heart block
3 58/M 45 — CAD Complete heart block
4 61/M 50 40 CAD, AF Sick sinus syndrome
5 75/M 35 58 CAD, NYHA III Complete heart block
6 62/M 45 46 CAD Complete heart block
7 58/M 45 41 CAD, AF Sick sinus syndrome
8 54/M 65 58 None Carotid sinus hypersensitivity
9* 53/M 28 — DCM, NYHA III Complete heart block
10* 80/M 25 52 DCM, NYHA IV Complete heart block
11* 55/M 30 57 CAD, NYHA III Sick sinus syndrome
12 53/M 48 58 CAD Complete heart block
13 57/M 45 42 CAD, AF Sick sinus syndrome
*Data excluded from ﬁnal analysis (see text). AF  atrial ﬁbrillation; CABG  coronary artery bypass graft; CAD 
coronary artery disease; DCM  dilated cardiomyopathy; HTD  hypertensive disease; M  male; NYHA III and
NYHA IV  New York Heart Association functional class III and IV, respectively; Pt  patient.
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to beat values. Nerve activity was quantiﬁed by custom-made
programs designed to identify sympathetic bursts above base-
line noise with the appropriate delay from the R wave of the
ECG (1.3 s [21]). Only bursts with a signal to noise ratio3:1
were included for analysis of sympathetic activity. Burst am-
plitude was normalized by assigning a calibration value of 1,000
to the largest sympathetic burst during single-chamber ventric-
ular pacing at 60 beats/min in each subject. This procedure
allowed quantitation of sympathetic activity with units that
could be compared among subjects. The area under each burst
was measured and the average burst area was derived for each
subject at each pacing condition. Total activity was calculated
for each subject at each pacing condition both as a function of
time (average burst area  bursts/min) and as a function of
heart rate (average burst area  bursts/100 heartbeats). The
results did not differ with either calculation; therefore, we
present only total sympathetic nerve activity as a function of
time.
We tested the hypothesis that changes of arterial pressure
during pacing provoke inverse changes of sympathetic nerve
activity. Therefore, we assessed the relation between systemic
hemodynamic variables and sympathetic outﬂow in each pa-
tient by performing regression analyses between average sys-
tolic and diastolic pressures and muscle sympathetic nerve
activity across all pacing modes. To make comparisons be-
tween pacing modes and rates, we used the optimal DDD
pacing for each subject, deﬁned as that AV delay with the
lowest sympathetic activity (60 beats/min: 150 ms, n  3;
200 ms, n  2; 250 ms, n  5; 100 beats/min: 250 ms in 9 of
10 patients). To determine differences between 1) basal con-
ditions and each pacing mode at each rate, and 2) basal
conditions and each AV delay during DDD pacing, indepen-
dent Student paired t tests were used with a Bonferroni
adjustment to avoid a type I error. Two-way analyses of
variance were used to determine the effects of mode and rate
on arterial pressures and sympathetic activity. A p level of 0.05
was considered signiﬁcant. All data are presented as mean
value  SE.
Results
A representative tracing of the ECG, arterial pressure and
sympathetic nerve activity from one subject at basal heart rate,
ventricular pacing and AV pacing is shown in Figure 1. With
the basal heart rate, arterial pressure was lowest (147  4 and
68  5 mm Hg) and muscle sympathetic nerve activity was
highest (5,105  805 U/min, Table 2). Most patients had
signiﬁcant inverse relations between systolic or diastolic pres-
Figure 1. Experimental record from one patient during basal heart
rate, single-chamber (VVI) pacing at 60 beats/min and dual-chamber
(DDD) pacing at 60 beats/min with an atrioventricular delay (AVD) of
200 ms.
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sure and muscle sympathetic nerve activity across the various
modes of pacing (average r  0.76). However, three patients
had no signiﬁcant relation between any measure of arterial
pressure and sympathetic activity (Fig. 2). These patients had
severe congestive heart failure (ejection fraction 30%) and
consistently higher sympathetic activity than that of the re-
maining patients (average of all pacing conditions 6,752 
1,157 vs. 3,358  494 U/min, p  0.05). Because severe
congestive heart failure impairs arterial baroreﬂex function
(22,23), and thus compromises the link between hemodynamic
alterations and sympathetic outﬂow, the data of these patients
were eliminated from all further analyses.
VVI pacing at 60 beats/min increased diastolic pressure
above that during basal heart rate but had no signiﬁcant effect
on muscle sympathetic nerve activity (Table 2, Fig. 3). VVI
pacing at 100 beats/min also increased diastolic pressure but, in
contrast, reduced sympathetic nerve activity below that during
basal heart rate by 48% on average. DDD pacing at 60
beats/min increased arterial pressures most at an AV delay of
200 ms (diastolic and systolic pressures p  0.05 vs. basal),
whereas it decreased sympathetic activity at AV delays of both
200 and 250 ms. DDD pacing at 100 beats/min resulted in
greater diastolic and systolic pressures than those measured
during the basal heart rate and in slightly higher arterial
pressures with longer AV delays. However, sympathetic activ-
ity declined similarly at all AV delays and was on average less
than half that recorded during the basal heart rate.
There were signiﬁcant differences in arterial pressure and
muscle sympathetic nerve activity in relation to pacing rate
and pacing mode (Fig. 3). Arterial pressures were higher and
muscle sympathetic nerve activity was lower during both VVI
and DDD pacing at 100 than at 60 beats/min. Moreover, DDD
pacing resulted in higher systolic and diastolic pressures and in
lower sympathetic nerve activity than did VVI pacing at both
pacing rates. There was no interaction between the effects of
pacing rate and mode. These results indicate that the effects of
both cardiac pacing rate and mode on sympathetic nerve
activity were inversely related to their effects on arterial
pressure.
Discussion
Our results are the ﬁrst to document an autonomic
advantage of dual-chamber pacing, on the basis of direct
measurements of sympathetic nervous outﬂow to the muscle
vasculature. Several studies (1–3,5) have documented the
Table 2. Arterial Pressures and Muscle Sympathetic Nerve Activity During Intrinsic Rhythm and During Single- and Dual-Chamber Pacing
Intrinsic
Rhythm VVI Pacing
DDD Pacing
AVD 150 ms AVD 200 ms AVD 250 ms
Systolic/Diastolic Arterial Pressure (mm Hg)
Basal rate 147  4/68  5
Pacing rate 60 beats/min 146  5/73  4* 159  7/74  4 163  8*/73  3* 157  7/73  2*
Pacing rate 100 beats/min 158  6/83  3* 170  10*/85  4* 173  9*/87  4* 174  11*/86  4*
Sympathetic Nerve Activity (U/min)
Basal rate 5,105  805
Pacing rate 60 beats/min 4,390  632 4,245  723 3,006  590* 2,961  570*
Pacing rate 100 beats/min 2,914  587* 2,316  413* 2,383  413* 2,396  540*
*p  0.05 versus intrinsic rhythm. Data presented are mean value  SE. AVD  atrioventricular delay; DDD  dual-chamber atrioventricular pacing; VVI 
single-chamber ventricular pacing.
Figure 2. Muscle sympathetic nerve activity with each
pacing mode in relation to diastolic blood pressure for
the three patients with heart failure who showed no
relation between arterial pressure and muscle sympa-
thetic activity.
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hemodynamic beneﬁts of DDD versus VVI pacing, suggest-
ing that DDD pacing may be the optimal pacing mode for
most patients. AV synchrony increases cardiac output (1,3),
which can lead to higher arterial pressures; increases in
arterial pressure result in baroreﬂex-mediated decreases in
sympathetic outﬂow. Our ﬁndings indicate an association
between the hemodynamic beneﬁts of dual-chamber pacing
and the resultant greater arterial pressures and lower sym-
pathetic activity.
VVI pacing generated lower arterial pressures and higher
sympathetic activity than did DDD pacing. The lack of AV
synchrony during VVI pacing may reduce average stroke
volume and cardiac output (4), necessitating greater sympa-
thetic vasomotor tone to maintain arterial pressure. Further-
more, ventricular pacing increases atrial natriuretic factor,
possibly by increasing atrial stretch during retrograde conduc-
tion (24). Because of its potent vasodilator effects (25), in-
creased atrial natriuretic factor may further reduce arterial
pressure, resulting in even greater sympathetic nervous out-
ﬂow. However, regardless of the mechanism, lower arterial
pressure during VVI pacing would result in higher baroreﬂex-
mediated sympathetic outﬂow.
Concerns about the long-term effects of VVI pacing have
recently been raised on the basis of retrospective uncontrolled
studies (13–18, 26–28) that suggest an increased risk of atrial
ﬁbrillation and higher mortality with ventricular pacing than
with DDD pacing. Similarly, in the only prospective random-
ized study reported to date (29), atrial pacing was associated
with a lower incidence of both atrial ﬁbrillation and thrombo-
embolic events when compared with VVI pacing. The present
ﬁndings may provide further insight into the mechanism of the
increased risk. For example, the deleterious effects of in-
creased sympathetic activity in the presence of structural heart
disease have been well documented (30). Thus, it is possible
that in patients with a VVI pacemaker, increased sympathetic
activity triggers lethal tachyarrhythmias leading to ventricular
tachycardia and ﬁbrillation, which may be responsible for the
twofold greater mortality in these patients than in patients with
a DDD pacemaker (14,27,28). Furthermore, greater sympa-
thetic outﬂow with ventricular pacing may decrease the atrial
refractory period, creating a milieu for increased atrial arrhyth-
mogenesis (31).
A poor correlation between arterial pressure and muscle
sympathetic nerve activity was observed in the three patients
with marked congestive heart failure. This effect may be
attributable to the markedly decreased arterial baroreﬂex
sensitivity observed in patients with overt heart failure (22,23).
Thus, cardiac pacing in patients with severe congestive heart
failure may be ineffective in decreasing sympathetic outﬂow;
however, our present data are insufﬁcient to elucidate this
issue.
Study limitations. Our study patients demonstrated heter-
ogeneous pacing indications and varying severity and etiology
of structural heart disease. Therefore, these results may not be
indicative of responses in patients with particular disease
states. Our measurements of sympathetic activity do not reﬂect
the long-term effects of VVI and DDD pacing modes on
sympathetic outﬂow, and we did not evaluate the effects of
pacing mode on systemic hemodynamic variables other than
arterial pressure. However, muscle sympathetic nerve activity
is strongly correlated with plasma norepinephrine levels (32)
and is tightly controlled by the arterial baroreﬂex (33). Thus, it
is reasonable to conclude from these data that higher arterial
pressures with cardiac pacing result in lower sympathetic
activation.
Conclusions. DDD pacing resulted in greater declines in
sympathetic activity than did VVI pacing. Decreased muscle
sympathetic nerve activity was related directly to greater
arterial pressure, implicating a baroreﬂex link between the
hemodynamic effect and the autonomic consequence of car-
diac pacing. These ﬁndings suggest that the DDD pacing mode
may be safer and more physiologic than the VVI pacing mode
by decreasing sympathetic outﬂow and thereby reducing the
risk of adverse outcome.
Figure 3. Average arterial pressures and sympathetic nerve activity
during basal heart rate, ventricular (VVI) pacing and optimal dual-
chamber (DDD) pacing at each rate in the 10 patients with inverse
relations between arterial pressure and sympathetic nerve activity.
*p  0.05 versus basal heart rate; †p  0.05 versus same pacing mode
at 60 beats/min; §p  0.05 versus VVI at same pacing rate. Values are
mean value  SE.
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